409 related articles for article (PubMed ID: 11232673)
1. Quality of life measurement clarifies the cost-effectiveness of Helicobacter pylori eradication in peptic ulcer disease and uninvestigated dyspepsia.
Groeneveld PW; Lieu TA; Fendrick AM; Hurley LB; Ackerson LM; Levin TR; Allison JE
Am J Gastroenterol; 2001 Feb; 96(2):338-47. PubMed ID: 11232673
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of the dyspeptic patient: a cost-utility study.
Ebell MH; Warbasse L; Brenner C
J Fam Pract; 1997 Jun; 44(6):545-55. PubMed ID: 9191627
[TBL] [Abstract][Full Text] [Related]
3. The health economics of Helicobacter pylori infection.
Moayyedi P
Best Pract Res Clin Gastroenterol; 2007; 21(2):347-61. PubMed ID: 17382282
[TBL] [Abstract][Full Text] [Related]
4. The effect of a Helicobacter pylori treatment strategy on health care expenditures in patients with peptic ulcer disease and dyspepsia.
Kearney DJ; Liu CF; Crump C; Brousal A
Am J Gastroenterol; 2003 Sep; 98(9):1952-62. PubMed ID: 14499771
[TBL] [Abstract][Full Text] [Related]
5. Economic evaluation of a randomized trial comparing Helicobacter pylori test-and-treat and prompt endoscopy strategies for managing dyspepsia in a primary-care setting.
Klok RM; Arents NL; de Vries R; Thijs JC; Brouwers JR; Kleibeuker JH; Postma MJ
Clin Ther; 2005 Oct; 27(10):1647-57. PubMed ID: 16330302
[TBL] [Abstract][Full Text] [Related]
6. Immediate eradication of Helicobacter pylori in patients with previously documented peptic ulcer disease: clinical and economic effects.
Fendrick AM; McCort JT; Chernew ME; Hirth RA; Patel C; Bloom BS
Am J Gastroenterol; 1997 Nov; 92(11):2017-24. PubMed ID: 9362183
[TBL] [Abstract][Full Text] [Related]
7. Cost-benefit analysis of testing for Helicobacter pylori in dyspeptic subjects.
Sonnenberg A
Am J Gastroenterol; 1996 Sep; 91(9):1773-7. PubMed ID: 8792696
[TBL] [Abstract][Full Text] [Related]
8. Impact of Helicobacter pylori eradication on dyspepsia, health resource use, and quality of life in the Bristol helicobacter project: randomised controlled trial.
Lane JA; Murray LJ; Noble S; Egger M; Harvey IM; Donovan JL; Nair P; Harvey RF
BMJ; 2006 Jan; 332(7535):199-204. PubMed ID: 16428249
[TBL] [Abstract][Full Text] [Related]
9. Helicobacter pylori-associated ulcer bleeding: should we test for eradication after treatment?
Pohl H; Finlayson SR; Sonnenberg A; Robertson DJ
Aliment Pharmacol Ther; 2005 Sep; 22(6):529-37. PubMed ID: 16167969
[TBL] [Abstract][Full Text] [Related]
10. Immediate endoscopy or initial Helicobacter pylori serological testing for suspected peptic ulcer disease: estimating cost-effectiveness using decision analysis.
Fendrick AM; Chernew ME; Hirth RA; Bloom BS
Yale J Biol Med; 1996; 69(2):187-95. PubMed ID: 9112750
[TBL] [Abstract][Full Text] [Related]
11. Long-term consequences of Helicobacter pylori eradication: clinical aspects.
Labenz J; Tillenburg B; Peitz U; Börsch G
Scand J Gastroenterol Suppl; 1996; 215():111-5. PubMed ID: 8722393
[TBL] [Abstract][Full Text] [Related]
12. Trends in the prevalence of peptic ulcer disease and Helicobacter pylori infection in family physician-referred uninvestigated dyspeptic patients in Hong Kong.
Xia B; Xia HH; Ma CW; Wong KW; Fung FM; Hui CK; Chan CK; Chan AO; Lai KC; Yuen MF; Wong BC
Aliment Pharmacol Ther; 2005 Aug; 22(3):243-9. PubMed ID: 16091062
[TBL] [Abstract][Full Text] [Related]
13. Helicobacter pylori eradication and standardized 3-month omeprazole therapy in functional dyspepsia.
Koskenpato J; Farkkilä M; Sipponen P
Am J Gastroenterol; 2001 Oct; 96(10):2866-72. PubMed ID: 11693319
[TBL] [Abstract][Full Text] [Related]
14. [Long-term course of reflux symptoms following Helicobacter pylori eradication].
Peitz U; Raps S; Plein K; Leodolter A; Hotz Dagger J; Malfertheiner P
Dtsch Med Wochenschr; 2004 Mar; 129(13):671-5. PubMed ID: 15026962
[TBL] [Abstract][Full Text] [Related]
15. The cost-effectiveness of competing strategies for the prevention of recurrent peptic ulcer hemorrhage.
Ofman J; Wallace J; Badamgarav E; Chiou CF; Henning J; Laine L
Am J Gastroenterol; 2002 Aug; 97(8):1941-50. PubMed ID: 12190158
[TBL] [Abstract][Full Text] [Related]
16. A cost analysis of a Helicobacter pylori eradication strategy in a large health maintenance organization.
Levin TR; Schmittdiel JA; Henning JM; Kunz K; Henke CJ; Colby CJ; Selby JV
Am J Gastroenterol; 1998 May; 93(5):743-7. PubMed ID: 9625120
[TBL] [Abstract][Full Text] [Related]
17. Reappraisal of non-invasive management strategies for uninvestigated dyspepsia: a cost-minimization analysis.
Ladabaum U; Chey WD; Scheiman JM; Fendrick AM
Aliment Pharmacol Ther; 2002 Aug; 16(8):1491-501. PubMed ID: 12182749
[TBL] [Abstract][Full Text] [Related]
18. A randomized controlled trial of test-and-treat strategy for Helicobacter pylori: clinical outcomes and health care costs in a managed care population receiving long-term acid suppression therapy for physician-diagnosed peptic ulcer disease.
Allison JE; Hurley LB; Hiatt RA; Levin TR; Ackerson LM; Lieu TA
Arch Intern Med; 2003 May; 163(10):1165-71. PubMed ID: 12767952
[TBL] [Abstract][Full Text] [Related]
19. Population-based and opportunistic screening and eradication of Helicobacter pylori. An analysis using trial baseline data. Leeds H. pylori Study Group.
Mason JM; Moayyedi P; Young PJ; Duffett S; Crocombe W; Drummond MF; Axon AT
Int J Technol Assess Health Care; 1999; 15(4):649-60. PubMed ID: 10645106
[TBL] [Abstract][Full Text] [Related]
20. Helicobacter pylori test-and-treat intervention compared to usual care in primary care patients with suspected peptic ulcer disease in the United States.
Ladabaum U; Fendrick AM; Glidden D; Scheiman JM
Am J Gastroenterol; 2002 Dec; 97(12):3007-14. PubMed ID: 12492183
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
